Why it's hard to trust trials sponsored by drug companies

Call for unconditional access to trial protocols

Scepticism about industry-sponsored drug trials will change only if there is unconditional access to trial protocols, argues a team of independent researchers.

pondering a question

Many drug companies are withholding information on trial protocols, the researchers write in the Journal of the Royal Society of Medicine.

Half of the commercially sponsored trial protocols in their study contained redactions, and they say it took three years to receive all 78 protocols requested, despite approved access from local ethics committees.